Stockreport

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Cullinan Oncology, Inc.  (CGEM) 
PDF CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating pot [Read more]